Akanda Corp. Announces Registered Direct Offering
Akanda Corp. (NASDAQ: 
AKAN), an international medical cannabis company, has recently disclosed its participation in a registered direct offering priced at the Minimum Price under Nasdaq rules. The company has entered into a securities purchase agreement with an accredited investor for the acquisition of 2,491,381 common shares at a purchase price of $0.1031. Additionally, the investor will obtain 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at $0.103 per share.
The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and are subject to certain beneficial ownership limitations as outlined in the pre-funded warrant.
Technical Outlook
Akanda Corp. (NASDAQ:AKAN) stock is up 24.98% as of the time of writing with a bullish Relative Strength Index (RSI) of 66.87 which is slightly overbought. The stock has risen from a falling wedge pattern.
AKAN), an international medical cannabis company, has recently disclosed its participation in a registered direct offering priced at the Minimum Price under Nasdaq rules. The company has entered into a securities purchase agreement with an accredited investor for the acquisition of 2,491,381 common shares at a purchase price of $0.1031. Additionally, the investor will obtain 21,756,922 pre-funded warrants to purchase 21,756,922 common shares at $0.103 per share. The pre-funded warrants are immediately exercisable at an exercise price of $0.0001 and are subject to certain beneficial ownership limitations as outlined in the pre-funded warrant.
Technical Outlook
Akanda Corp. (NASDAQ:
AKAN) stock is up 24.98% as of the time of writing with a bullish Relative Strength Index (RSI) of 66.87 which is slightly overbought. The stock has risen from a falling wedge pattern.
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
1) Download our Mobile App >> link-to.app/dexwirenews
2) Join our Telegram >> t.me/DEXWireNews
3) Sign Up for Text Alerts >>
dexwirenews.com/TEXT
4) Follow @DEXWireNews on Social Media
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.